Status of Malaria Vaccine Introduction—Africa, 2019–2024
The American Journal of Tropical Medicine and Hygiene · 04.11.2026 · 115 (5) · 1040-1043
DOI: 10.4269/ajtmh.26-0338 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, erschienen am 04.11.2026. Verfasst von Anh N Ly und 7 weiteren Autor:innen. Beteiligte Einrichtung: Epidemic Intelligence Service, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Malaria Vaccines, Malaria, Immunization Programs. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Malaria remains the primary cause of death among children younger than 5 years old in Africa. During 2019–2023, Ghana, Kenya, and Malawi piloted introduction of the first malaria vaccine, RTS,S/AS01, through the Malaria Vaccine Implementation Program. There are two malaria vaccines prequalified by the WHO: RTS,S/AS01 and R21/Matrix-M. The vaccines are recommended for children younger than 5 years old in endemic areas, prioritizing areas of moderate to high transmission. Data on vaccine introduction and doses shipped were obtained from the WHO and the United Nations Children’s Fund. As of December 2024, 17 countries in Africa had introduced the malaria vaccine with support from Gavi, the Vaccine Alliance, and another eight countries had approval for Gavi support. During 2023–2024, a total of 13,250,098 vaccine doses were shipped to countries. The introduction of the malaria vaccine presents an integration opportunity with preventive health services to reduce child morbidity and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Epidemic Intelligence Service, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Global Immunization Division, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- World Health Organization, Geneva, Switzerland.
Zitieren
APA
Ly, A. N., Walldorf, J. A., Hamel, M. J., Pellaux-Furrer, E., Okine, R. N. A., Magafu, M. G. M. D., Patel, J. C., & Hyde, T. B. (2026). Status of Malaria Vaccine Introduction—Africa, 2019–2024. The American Journal of Tropical Medicine and Hygiene, 115(5), 1040-1043. https://doi.org/10.4269/ajtmh.26-0338
Vancouver
Ly AN, Walldorf JA, Hamel MJ, Pellaux-Furrer E, Okine RNA, Magafu MGMD, et al. Status of Malaria Vaccine Introduction—Africa, 2019–2024. The American Journal of Tropical Medicine and Hygiene. 2026;115(5):1040-1043. doi:10.4269/ajtmh.26-0338
BibTeX
@article{Ly2026,
author = {Ly, Anh N and Walldorf, Jenny A and Hamel, Mary J and Pellaux-Furrer, Eliane and Okine, Rafiq Nii Attoh and Magafu, Mgaywa G M D and Patel, Jaymin C and Hyde, Terri B},
title = {Status of Malaria Vaccine Introduction—Africa, 2019–2024},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2026},
volume = {115},
number = {5},
pages = {1040--1043},
doi = {10.4269/ajtmh.26-0338}
}
EUVIMED